VAERS reports by lot

GSK DTaP/Tdap lot H9FM5: VAERS reports

73 VAERS reports list lot H9FM5 as a GSK DTaP/Tdap vaccine, received between 2021-11-06 and 2023-11-09. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
73
Reports
0%
Marked serious
0
With a death outcome
19
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1365%
Dermatological (non-injection-site)315%
Neurological15%
Cardiac / Cardiovascular15%
Allergic / Anaphylactic15%
Psychiatric / Neuropsychiatric15%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas7
California6
Michigan5
Virginia5
New Mexico4
Kansas3
Oregon3
Tennessee2
Ohio2
North Carolina2
Maine2
Indiana2

Reports by month received

2021-111
2021-121
2022-0312
2022-044
2022-053
2022-063
2022-073
2022-086
2022-092
2022-102
2022-111
2022-124
2023-014
2023-022
2023-045
2023-0515
2023-062
2023-072
2023-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.